2023 Q4 Form 10-Q Financial Statement

#000137647423000499 Filed on November 16, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $126.3K $125.6K $9.200K
YoY Change 1478.38% 1265.11% -38.34%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $50.00 $53.00 $0.00
YoY Change -100.0%
% of Gross Profit
Operating Expenses $126.8K $131.7K $9.555K
YoY Change 1416.27% 1278.61% -37.95%
Operating Profit -$126.8K -$131.7K -$9.555K
YoY Change 1416.27% 1278.61% -37.95%
Interest Expense -$2.630K $2.533K $579.00
YoY Change 1778.57% 337.48% -198.14%
% of Operating Profit
Other Income/Expense, Net -$2.533K -$579.00
YoY Change 337.48% -2.53%
Pretax Income -$129.4K -$134.3K -$10.13K
YoY Change 1424.03% 1224.84% -36.66%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$129.4K -$134.3K -$10.13K
YoY Change 1424.03% 1224.84% -36.66%
Net Earnings / Revenue
Basic Earnings Per Share -$0.02 $0.00
Diluted Earnings Per Share -$0.02 -$0.02 -$35.55
COMMON SHARES
Basic Shares Outstanding 5.477M shares 547.5M shares 284.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $480.00 $1.440K $150.00
YoY Change 242.86% 860.0% -97.13%
Cash & Equivalents $480.00 $1.436K $152.00
Short-Term Investments
Other Short-Term Assets $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $480.00 $1.436K $152.00
YoY Change 247.83% 844.74% -97.09%
LONG-TERM ASSETS
Property, Plant & Equipment $930.00 $981.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $930.00 $981.00 $0.00
YoY Change -100.0%
TOTAL ASSETS
Total Short-Term Assets $480.00 $1.436K $152.00
Total Long-Term Assets $930.00 $981.00 $0.00
Total Assets $1.410K $2.417K $152.00
YoY Change 921.74% 1490.13% -98.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $1.246K $104.0K
YoY Change -100.0% -98.8% 14.45%
Accrued Expenses $226.7K $111.6K $177.8K
YoY Change 27.48% -37.26% 1.13%
Deferred Revenue
YoY Change
Short-Term Debt $111.0K $0.00 $19.94K
YoY Change 456.67% -100.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $350.2K $221.8K $335.3K
YoY Change 1.88% -33.84% 9.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $350.2K $221.8K $335.3K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $350.2K $221.8K $335.3K
YoY Change 1.88% -33.84% 9.86%
SHAREHOLDERS EQUITY
Retained Earnings -$8.943M -$8.814M -$8.624M
YoY Change 3.6% 2.2%
Common Stock $5.477K $5.477K $284.9K
YoY Change -98.08% -98.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$348.8K -$219.4K -$335.1K
YoY Change
Total Liabilities & Shareholders Equity $1.410K $2.417K $152.00
YoY Change 921.74% 1490.13% -98.14%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$129.4K -$134.3K -$10.13K
YoY Change 1424.03% 1224.84% -36.66%
Depreciation, Depletion And Amortization $50.00 $53.00 $0.00
YoY Change -100.0%
Cash From Operating Activities -$15.46K -$60.29K -$9.160K
YoY Change 44.35% 558.19% -25.22%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 14.50K 31.72K 8.690K
YoY Change 35.51% 265.02% -49.74%
NET CHANGE
Cash From Operating Activities -15.46K -60.29K -9.160K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 14.50K 31.72K 8.690K
Net Change In Cash -960.0 -28.57K -470.0
YoY Change 9500.0% 5978.72% -109.33%
FREE CASH FLOW
Cash From Operating Activities -$15.46K -$60.29K -$9.160K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52390
dei Entity Registrant Name
EntityRegistrantName
Advanced Voice Recognition Systems, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0511932
dei Entity Address Address Line1
EntityAddressAddressLine1
7659 E. Wood Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85260
dei City Area Code
CityAreaCode
(480)
dei Local Phone Number
LocalPhoneNumber
704-4183
dei Security12b Title
Security12bTitle
Common Stock par value $0.001 per share
dei Trading Symbol
TradingSymbol
AVOI
dei Security Exchange Name
SecurityExchangeName
NONE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5476685 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1436 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
138 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
1436 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
138 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
981 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
981 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
0 usd
CY2023Q3 us-gaap Assets
Assets
2417 usd
CY2022Q4 us-gaap Assets
Assets
138 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1246 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
101778 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
107181 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
162380 usd
CY2023Q3 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
0 usd
CY2022Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
19935 usd
CY2023Q3 fil Advance From Related Party
AdvanceFromRelatedParty
109000 usd
CY2022Q4 fil Advance From Related Party
AdvanceFromRelatedParty
44188 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
4389 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
15450 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
221816 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
343731 usd
CY2023Q3 us-gaap Liabilities
Liabilities
221816 usd
CY2022Q4 us-gaap Liabilities
Liabilities
343731 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
547500000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
547500000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5476685 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5476685 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
284920269 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
284920269 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5477 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
284920 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
0 shares
CY2022Q4 us-gaap Common Stock Shares Subscribed But Unissued
CommonStockSharesSubscribedButUnissued
262580 shares
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8588626 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7740920 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8813502 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8632013 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-219399 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-343593 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2417 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
107047 usd
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
25 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
156280 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
4071 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
17078 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
6726 usd
us-gaap Professional Fees
ProfessionalFees
59768 usd
us-gaap Professional Fees
ProfessionalFees
26397 usd
CY2023Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1461 usd
CY2022Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2447 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
4235 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6463 usd
CY2023Q3 us-gaap Depreciation
Depreciation
53 usd
CY2022Q3 us-gaap Depreciation
Depreciation
0 usd
us-gaap Depreciation
Depreciation
70 usd
us-gaap Depreciation
Depreciation
0 usd
CY2023Q3 us-gaap Other General Expense
OtherGeneralExpense
6087 usd
CY2022Q3 us-gaap Other General Expense
OtherGeneralExpense
357 usd
us-gaap Other General Expense
OtherGeneralExpense
7192 usd
us-gaap Other General Expense
OtherGeneralExpense
1346 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
131726 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
9555 usd
us-gaap Operating Expenses
OperatingExpenses
227545 usd
us-gaap Operating Expenses
OperatingExpenses
38277 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-131726 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9555 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-227545 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-38277 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
50445 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
2533 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
579 usd
us-gaap Interest Expense
InterestExpense
4389 usd
us-gaap Interest Expense
InterestExpense
1818 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2533 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-579 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46056 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1818 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-134259 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-10134 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-181489 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-40095 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-134259 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10134 usd
us-gaap Net Income Loss
NetIncomeLoss
-181489 usd
us-gaap Net Income Loss
NetIncomeLoss
-40095 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5475574 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
284920269 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5475217 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
284920269 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-300004 usd
CY2022Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
5000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-20183 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-315187 usd
CY2022Q2 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
0 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-9778 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-324965 usd
CY2022Q3 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
0 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-10134 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-335099 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-343593 usd
CY2023Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
19353 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-324240 usd
CY2023Q2 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
0 usd
CY2023Q2 us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
305683 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-66583 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-85140 usd
CY2023Q3 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
0 usd
CY2023Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-134259 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-219399 usd
us-gaap Profit Loss
ProfitLoss
-181489 usd
us-gaap Profit Loss
ProfitLoss
-40095 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
70 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
us-gaap Accretion Expense
AccretionExpense
4389 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
0 usd
us-gaap Increase Decrease In Operating Assets
IncreaseDecreaseInOperatingAssets
0 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-155731 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4306 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-332761 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35789 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1051 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1051 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
305683 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
59638 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
19935 usd
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
109000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
18793 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
335110 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23793 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1298 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11996 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12148 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1436 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
152 usd
us-gaap Interest Paid
InterestPaid
15450 usd
us-gaap Interest Paid
InterestPaid
1495 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
2 usd
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"><b>Note 1.     Nature of Operations</b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"><b><i>Company Overview</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">The operations of Advanced Voice Recognition Systems, Inc. (“AVRS” or the “Company”) commenced in 1994 with a predecessor entity called NCC, Inc. NCC, Inc. was incorporated on March 15, 1994 in the State of Ohio. NCC, Inc. operated as a software and hardware development company that marketed voice recognition and transcription products for commercial applications.</p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">In May 2000, WG Investments, LLC acquired the assets of NCC, Inc. and subsequently changed its name to NCC, LLC. NCC, LLC (also a predecessor to AVRS) continued the operations of NCC, Inc. until approximately December 31, 2001, when shifts in the industry’s markets caused NCC, LLC to suspend its operations.</p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">AVRS was incorporated in the State of Colorado on July 7, 2005. In September 2005, the members of NCC, LLC transferred all of their membership interests in NCC, LLC to AVRS in exchange for 93,333,333 shares (post-recapitalization) of AVRS common stock. In December 2005, the Board of Directors approved a 1.5-to-1 stock split issuing 46,666,667 common shares (post-recapitalization), which increased the number of common shares outstanding to 140 million shares (post-capitalization). Following the incorporation of AVRS, the Company initiated a new business plan and intends to continue its operations in the voice recognition and transcription industry.</p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">AVRS is a software development company specializing in speech recognition technologies. AVRS has successfully obtained patent protection of its proprietary technology (refer to Note 3, Intangible Assets).   The Company continues to explore all options to monetize and enforce our patent portfolio through patent enforcement and licensing of the six patents issued. </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><span style="background-color:#FFFFFF"><b><i>Amended and Restated Articles of Incorporation</i></b></span></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><span style="background-color:#FFFFFF">On July 3, 2023, the Company filed Amended and Restated Articles of Incorporation for the State of Nevada where the authorized number of common shares were amended to five hundred seventy-two million five hundred thousand shares (572,500,000) consisting of five hundred forty-seven million five hundred thousand (547,500,000) common shares with par value of $0.001 per share and twenty- five million (25,000,000) preferred shares with par value of $0.001.</span></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"><b><i>Stock Purchase Agreements</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">During year ended December 31, 2022, the Company entered into a Stock Purchase Agreements for the private sale to one person or entity of an aggregate of 3,334 shares of the common stock for aggregate proceeds of $5,000 which was paid in full in the period.  On December 29, 2022, the Company entered into an Escrow agreement for the purchase of 262,579,731 shares of the Company’s Common Stock.  The shares were in Escrow until full payment was received on April 19, 2023 and released to the purchaser (Note 7).</p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify"><b><i>Commitments and Contingencies</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">On April 20, 2015 Advanced Voice Recognition Systems, Inc. (“AVRS”) entered into a Material Letter Agreement with an unrelated third party (“AIP”) in which they promise to pay to patent legal counsel funds to continue prosecuting Patents on behalf of AVRS.  AVRS promises to pay AIP, or to such other holder of this promissory note (Note) as designate, the principal, together with a premium of ten percent (10%) of Principle and two percent (2%) of proceeds received by Company from a Monetization Event initiated by AIP.</p> <p style="font:11pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">On September 21, 2018, Advanced Voice Recognition Systems, Inc. (“<span style="border-bottom:1px solid #000000">AVRS</span>”) and Buether Joe &amp; Carpenter, LLC (“BJC) entered into a Letter of Engagement for Legal Services Limited Scope Agreement (“<span style="border-bottom:1px solid #000000">Agreement</span>”) with Schmeiser, Olsen &amp; Watts LLP (“<span style="border-bottom:1px solid #000000">the Firm</span>”) pursuant to which the Firm will serve as local counsel in the United States District Court, District of Arizona.  The Firm has been hired to represent AVRS as local counsel in connection with forthcoming litigation in the U.S. District Court, District of Arizona.    AVRS may terminate the Agreement at any time.</p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"><b><i>Litigation</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">From time to time, we may become involved in legal proceedings or other litigation that we consider to be a part of the ordinary course of our business. Presently, we are not involved in any litigation and to the best knowledge of management, there are no legal proceedings pending or threatened against the Company.</p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><span style="background-color:#FFFFFF"><b><i>Reverse Split and Increase in Authorized Shares</i></b></span></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><span style="background-color:#FFFFFF">On July 5, 2023, the Shareholders approved to authorize a reverse split of 1 new share for one hundred old shares basis as of September 30, 2023 where fractional shares will be rounded up to the next whole share.  In addition, the Shareholders approved to authorize twenty-five million (25,000,000) preferred shares for a total of 572,500,000 authorized shares of the company. The Articles of Information with the state of Nevada were amended to reflect the approved actions of the Shareholders.</span></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><span style="background-color:#FFFFFF"><b><i>Letter of Intent for Business Acquisition</i></b></span></p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;color:#000000;text-align:justify"><span style="background-color:#FFFFFF">On July 14, 2023, the Company issued a letter of intent to acquire 100% of issued and outstanding common and preferred shares of Rivulet Media, Inc, a Delaware corporation, with the ticker symbol (RIVU) in a stock for stock transaction subject to the completion of a reverse stock split of 100 to 1 of the Company’s issued and outstanding shares of common stock and an increase of authorized preferred shares by twenty-five million (25,000,000).</span></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"><b><i>Reverse Stock Split</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">The Company effected a 1-for 100 reverse stock split of its outstanding shares of common stock on July 3, 2023.  The reverse stock split did not change the number of authorized shares of common stock or par value.  All references in these condensed financial statements to share, share prices, and other per share information in all periods for 2023 have been adjusted, on a retrospective basis, to reflect the reverse stock split.</p>
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2005-07-07
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
138 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-219399 usd
us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000 usd
CY2023Q3 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
109000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"><b><i>Use of Estimates</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1436 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
127491 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
127491 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
127491 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
127491 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1051 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
70 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
981 usd
CY2023Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
107181 usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
162380 usd
us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
156280 usd
us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
4071 usd
us-gaap Proceeds From Loans
ProceedsFromLoans
109000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
19935 usd
us-gaap Business Combination Control Obtained Description
BusinessCombinationControlObtainedDescription
Company entered into an Escrow agreement for the purchase of 262,579,731 shares of the Company’s Common Stock
CY2023Q3 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
0.51 pure
CY2023Q4 us-gaap Subsequent Events Date
SubsequentEventsDate
2023-10-25
CY2023Q4 us-gaap Subsequent Event Description
SubsequentEventDescription
Registrant filed a Certificate of Designation, with the State of Nevada, on ten million shares of its twenty-five million shares of Series A Preferred stock, par value $0.001

Files In Submission

Name View Source Status
0001376474-23-000499-index-headers.html Edgar Link pending
0001376474-23-000499-index.html Edgar Link pending
0001376474-23-000499.txt Edgar Link pending
0001376474-23-000499-xbrl.zip Edgar Link pending
avoi-20230930.htm Edgar Link pending
avoi-20230930.xsd Edgar Link pending
avrs_ex31z1.htm Edgar Link pending
avrs_ex31z2.htm Edgar Link pending
avrs_ex32z1.htm Edgar Link pending
avrs_ex3z1-0001.jpg Edgar Link pending
avrs_ex3z1-0002.jpg Edgar Link pending
avrs_ex3z1-0003.jpg Edgar Link pending
avrs_ex3z1-0004.jpg Edgar Link pending
avrs_ex3z1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
avoi-20230930_lab.xml Edgar Link unprocessable
avoi-20230930_def.xml Edgar Link unprocessable
avoi-20230930_cal.xml Edgar Link unprocessable
avoi-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
avoi-20230930_htm.xml Edgar Link completed
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending